ZCCHC3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.11240000544299E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.0275781881528E-13 |
Normal-vs-Stage2 |
2.617700E-02 |
Normal-vs-Stage3 |
1.953250E-01 |
Normal-vs-Stage4 |
4.254200E-02 |
Stage1-vs-Stage2 |
2.130300E-02 |
Stage1-vs-Stage3 |
5.76730000423353E-08 |
Stage1-vs-Stage4 |
1.94157999999778E-05 |
Stage2-vs-Stage3 |
1.756820E-01 |
Stage2-vs-Stage4 |
4.716400E-01 |
Stage3-vs-Stage4 |
4.716000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.61110000007625E-07 |
Normal-vs-AfricanAmerican |
3.69820000001297E-06 |
Normal-vs-Asian |
8.229800E-01 |
Caucasian-vs-AfricanAmerican |
9.357500E-03 |
Caucasian-vs-Asian |
1.678570E-01 |
AfricanAmerican-vs-Asian |
4.316000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.00809999999496E-05 |
Normal-vs-Female |
1.19940002374364E-09 |
Male-vs-Female |
4.118200E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
5.084400E-02 |
Normal-vs-Age(41-60Yrs) |
1.16870000343994E-08 |
Normal-vs-Age(61-80Yrs) |
1.67064999999633E-05 |
Normal-vs-Age(81-100Yrs) |
2.977800E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.113800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.649400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.224600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.621970E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.681380E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.118800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.369300E-04 |
Normal-vs-Grade 2 |
3.46278561380586E-13 |
Normal-vs-Grade 3 |
1.177120E-03 |
Normal-vs-Grade 4 |
8.350400E-01 |
Grade 1-vs-Grade 2 |
9.540900E-03 |
Grade 1-vs-Grade 3 |
3.79080000001419E-06 |
Grade 1-vs-Grade 4 |
1.59759999673881E-08 |
Grade 2-vs-Grade 3 |
1.72046999999953E-05 |
Grade 2-vs-Grade 4 |
1.2141999627957E-09 |
Grade 3-vs-Grade 4 |
8.555800E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.62447832963153E-12 |
Normal-vs-ccB subtype |
9.789800E-01 |
ccA subtype-vs-ccB subtype |
4.44089209850063E-16 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.990030E-04 |
Normal-vs-N1 |
7.617700E-02 |
N0-vs-N1 |
1.341530E-03 |
|
|